Aiolos Bio

Series-A
aiolosbio.com Biotech & Healthcare San Francisco, United States Founded 2023 11–50 employees
Total Funding $245M
Latest Round $245M Series-A
Last Announced Nov 20, 2023
Investors 5 Backers
Decision Makers 4 Available

About Aiolos Bio

Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters San Francisco, United States
Year Founded 2023
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website aiolosbio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $245,000,000 · Series-A

    Backed by Atlas Venture

  2. Milestone

    Company founded

    San Francisco, United States

Investors & Backers

5
Atlas Venture
Lead
Bain Capital Life Sciences
Forbion Capital Partners
RA Capital Management
Sofinnova Partners

Funding History

1 Round
Series-A equity · Nov 20, 2023

Round backers: Atlas Venture

$245,000,000 startupintros.com

Founders & Leadership

2

Ashley Taylor

Chief Technical Officer

Work email & phone locked Unlock →

Khurem Farooq

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts